BY JOHN HOUANIHAU
The Bill and Legislation committee (BLC) have raised concerns about weaknesses in existing laws, including sentencing practices, parole eligibility, and the possibility of capital punishment.
During BLC hearing into the Dangerous Drug amendment Bill with Public Solicitor, BLC members questioned whether current legal frameworks are strong enough to address serious crimes and whether some provisions should be revisited as part of broader legislative reforms.
One issue raised by Leader of Opposition Mathew Wale, was the debate around the death penalty and whether it could ever be considered in the Solomon Islands legal system.
However Public Solicitor George Gray questioned whether authorities, including the Governor-General, would be prepared to authorise such a sentence if the law allowed it.
Mr Gray said that international human rights conventions which Solomon Islands is a party to, largely discourage or abolish capital punishment, emphasising that many countries have moved away from practices such as hanging.
The discussion also focused on how life imprisonment is applied in practice within the country’s justice system.
Gray said that life sentences often include a non-parole period set by the court, meaning offenders can apply for parole after serving a specified minimum term.
“For example, someone convicted of murder may receive life imprisonment with a non-parole period of 15 years. After those 15 years, the person becomes eligible to apply for parole, subject to good behaviour and other conditions,” he said.
The BLC also questioned the rationale behind remission provisions under correctional service regulations, which allow prisoners to be released earlier than their full sentence if they demonstrate good behaviour.
The BLC committee encouraged the Public Solicitor’s Office to review relevant legislation and identify areas where amendments may be needed.
The BLC is considering recommending consequential amendments to several laws to strengthen the overall legal framework when it comes to illegal drugs.
For feedback, contact: [email protected]
Editor: [email protected]
